baber/WOPTO huggingface dataset:
Patent DE-69520319-D1 (DE)
Inventor: IIYAMA SHIGEO
IPC: C01F11/46
Filed: 1995-09-30
Granted: 2001-04-19
Abstract: A method for desulfurization which comprises a desulfurization step of absorbing and removing sulfur oxides in an exhaust gas by a solution containing a Mg-based desulfurizing agent, an oxidation step of treating the treatment liquid with a gas containing oxygen, a double decomposition step of adding basic calcium compounds to the solution obtained in the oxidation step to carry out a reaction, a separation step of separating a slurry of a mixture of Mg(OH)2 and gypsum dihydrate obtained in the double decomposition step by a wet classifier, a step of returning a Mg(OH)2 slurry separated in the separation step to the desulfurization step, a step of treating a gypsum dihydrate slurry in the oxidation step to convert accompanying Mg(OH)2 into MgSO4, a sedimentation separation step of separating gypsum dihydrate, and a step of returning a supernatant liquid in the sedimentation separation step to the double decomposition step to treat the supernatant liquid; and a method for desulfurization which comprises adding, to the double decomposition step, basic compounds obtained calcining and digesting a dolomite in place of basic calcium compounds to carry out double decomposition, separating the solution subjected to the double decomposition by a wet classifier, returning an amount of a Mg(OH)2 slurry necessary for the desulfurization to a desulfurizing tower, concentrating, separating and taking the remaining Mg(OH)2 slurry from the system, oxidizing a gypsum dihydrate slurry to convert accompanying Mg(OH)2 into MgSO4, sedimenting, separating and taking out gypsum dihydrate as gypsum, and then subjecting the resultant supernatant to the double decomposition treatment together with the oxidized desulfurizing treatment liquid.
Patent DE-69531295-D1 (DE)
Inventor: WASASTJERNA JAN
IPC: A23L3/34
Filed: 1995-04-06
Granted: 2003-08-21
Abstract: The invention relates to a method for extending the useful life of a deep-frying fat. In the method, into the fat during the deep-frying and possibly the storage an inert gas stream, preferably nitrogen, is fed in finely divided form.
Patent DE-69533375-D1 (DE)
Inventor: KAWAHARA TOSHIRO
IPC: H04B3/23
Filed: 1995-05-02
Granted: 2004-09-16
Abstract: The present invention relates to an echo canceller using an up-sampler (32) to increase the sampling rate of the transmit signal (Rin) and another up-sampler (33) to increase the sampling rate of the receive signal (Sin). The sampling rate of the echo replica signal outputted from the echo path estimation circuit (3) is reduced by a down-sampler (34).
Patent DE-69534514-D1 (DE)
Inventor: WILLIAMS CHARLES
IPC: G01N27/30
Filed: 1995-06-23
Granted: 2005-11-17
Abstract: PCT No. PCT/GB95/01476 Sec. 371 Date Jan. 27, 1997 Sec. 102(e) Date Jan. 27, 1997 PCT Filed Jun. 23, 1995 PCT Pub. No. WO96/14769 PCT Pub. Date May 23, 1996A method for the production of electrodes, especially microelectrodes, in which the (micro) electrode consists essentially of an electrically-insulating material through which apertures are formed to reveal the electrically-conducting material, is characterized in that aperture as formed by the use of a light-hardened (photopolymerizing) resist or light-softened (photoinduced breaking of bonds) resist.
Patent DE-69610848-D1 (DE)
Inventor: CORZANI ITALO
IPC: A61F13/15
Filed: 1996-12-03
Granted: 2000-12-07
Abstract: The present invention relates to absorbent articles such as sanitary napkins and panty liners which are breathable by the incorporation of a breathable backsheet and have a reduced tendency to exhibit garment wet through. The backsheet comprises at least one vapour permeable, apertured layer comprising a non soluble, liquid shrinkable material such as polyvinyl alcohol. Upon contact with the fluid discharge the material shrinks thereby causing the apertures of the layer to close and hence prevent the passage of liquid through the backsheet onto the garment of the wearer.
Patent DE-69618700-D1 (DE)
Inventor: KONDO TOMOYUKI
IPC: C09K19/20
Filed: 1996-02-22
Granted: 2002-03-14
Abstract: A novel liquid crystalline compound having a large dielectric anisotropy value, a small change in the threshold voltage depending upon temperatures, and an improved solubility in other liquid crystal materials at low temperatures, and a liquid crystal composition containing the compound are provided,   which liquid crystalline compound is expressed by the formula (1) wherein R is H or an alkyl group of 1 to 10C; ℓ is an integer of 1 to 9; m, n and o are each independently 0 or 1; A<sub>1</sub>, A<sub>2</sub> and A<sub>3</sub> are each independently trans-1,4-cyclohexylene group, 1,4-pheylene group, one or more H atoms on the ring of which group may be replaced by F, or the like group; Z<sub>1</sub>, Z<sub>2</sub> and Z<sub>3</sub> are each independently -COO-, etc., but at least one member of them is -COO-; X is CF<sub>3</sub>,etc.; and Y<sub>1</sub> and Y<sub>2</sub> are each independently H or F.
Patent DE-69621270-D1 (DE)
Inventor: TAKAHASHI MISAKO
IPC: G06F3/06
Filed: 1996-02-16
Granted: 2002-06-27
Abstract: A memory control apparatus (3) according to the invention is interposed between a central processing unit (1) and a memory device (2) to store data and has: a channel control unit (35) to control a data transfer to/from the central processing unit (1); a drive control unit (36) to control a data transfer to/from the memory device (2); a plurality of cache memories (33, 34) to temporarily store the data which is transferred between the central processing unit (1) and the memory device (2); and a cache memory control unit (37) having selecting means for selecting the cache memory to store the data which is transferred from the memory device (2). The memory control apparatus (3) selects the cache memory to store the data so as to almost equalize use amounts in the plurality of cache memories, thereby controlling the allocation of the cache memories and enabling a cache memory space to be effectively used.
Patent DE-69629314-D1 (DE)
Inventor: SHAW THOMAS J
IPC: A61M5/178
Filed: 1996-04-24
Granted: 2003-09-04
Abstract: A tamperproof retractable syringe structure comprises a one piece hollow outer body (12) with an elongated barrel (14) and nose (16) and a plunger assembly (32) disposed partially within the barrel (14). A retraction mechanism (20) is sealingly disposed in the nose (16) with a retainer member (66a) surrounding a head (72a) of a needle holder (22a) as a further part of the retraction mechanism (20).  Such a retraction mechanism (20) can be disposed in a nose portion (16) of the syringe body (12) having retractable parts comprising the releasable needle holder (22a) and a needle (28) frictionally held by the wall of the syringe body (12). The retraction mechanism (20) includes a non-retractable part and according to the invention a reliable retractable tamperproof syringe with multiple tamperproof features is obtained which operates on the principle which permits low cost parts which are few in number and well suited for high-speed mass production and assembly.
Patent DE-69629819-D1 (DE)
Inventor: MOHR IAN J
IPC: A61K35/76
Filed: 1996-07-25
Granted: 2003-10-09
Abstract: Isolated tumoricidal herpetic viruses, in particular neurotrophic herpes viruses, T-lymphotrophic viruses, and B-lymphotrophic viruses, which are avirulent and capable of selectively replicating in and destroying neoplastic cells, and pharmaceutical compositions, vaccines, and methods of destroying neoplastic cells employing the isolated tumoricidal herpetic viruses are described. A method of isolating tumoricidal herpetic viruses by sequentially passaging attenuated, avirulent herpetic viruses on neoplastic cells which fail to support replication of the herpetic viruses and isolating the viruses which grow on the neoplastic cells is also described. Herpes simplex virus mutants having a genome from which the  gamma 34.5 genes have been deleted and which require at least one additional mutation to produce a non-neurovirulent herpes simplex virus which selectively replicates in and destroys neoplastic cells are also described.
Patent DE-69632855-D1 (DE)
Inventor: FORMAN MICHAEL R
IPC: A61M29/02
Filed: 1996-12-03
Granted: 2004-08-12
Abstract: A dilatation balloon (20,98) is fabricated according to a process that yields high hoop strength and uniformity in balloon wall thickness. A length of tubing (34) is axially elongated and radially expanded in a form (36) to provide the requisite biaxial orientation and strength. Then, an excimer laser (46,66,84) is used to remove the polymeric material by photo-chemical ablation, virtually without thermal effects. Dilatation balloon walls are thinned primarily along tapered sections (26,28) between proximal and distal balloon stems (30,32) and a medial working section (24) of the balloon. Material removal, particularly near the balloon stems, enables tighter wrapping of the balloon for a reduced delivery profile, and reduces rigidity near the stems for better maneuverability of the catheter in tortuous passageways. The balloon tapered sections are reduced to a wall thickness substantially equal to that of the medial section. Alternatively, an array of grooves (96) is formed in each tapered section. <IMAGE>
Patent DE-69633818-D1 (DE)
Inventor: YOSHIMURA SATOMICHI
IPC: A23L1/30
Filed: 1996-08-07
Granted: 2004-12-16
Abstract: A preventive or remedy for diseases caused by abnormalities in cartilage tissues or a drink or food therefor which comprises as the active ingredient an omega-9 unsaturated fatty acid.
Patent DE-69637992-D1 (DE)
Inventor: MOCHIDA ISAO
IPC: B01J21/18
Filed: 1996-09-24
Granted: 2009-09-24
Abstract: This invention relates to a technique for removing nitrogen oxides (NOx) present in exhaust gases discharged from boilers and the like. When the temperature of the exhaust gas is 100 DEG C or below, a heat-treated active carbon produced by heat-treating a raw active carbon at 600 to 1,200 DEG C in a non-oxidizing atmosphere so as to remove oxygen-containing functional groups present at the surfaces thereof and thereby reduce the atomic surface oxygen/surface carbon ratio to 0.05 or less is preferably used. When the temperature of the exhaust gas exceeds 100 DEG C, a heat-treated active carbon produced by heat-treating a raw active carbon at 600 to 1,200 DEG C in a non-oxidizing atmosphere and activating the surfaces thereof with sulfuric acid or nitric acid to impart oxidizing oxygen-containing functional groups thereto is preferably used. <IMAGE>
Patent DE-69723130-D1 (DE)
Inventor: SAMSON GENE
IPC: A61L29/00
Filed: 1997-02-28
Granted: 2003-08-07
Abstract: This is a perfusion catheter having an inflatable membrane or balloon located at the distal end of the catheter shaft. The shaft is comprised of an outer tubing assembly and an inner tubing assembly separated by an open annulus for inflating and deflating the inflatable membrane. The outer tubing assembly is made up of at least one polymeric layer and a super-elastic braid. The inner tubing assembly is made up of one or more layers of polymeric tubing, the innermost of which is preferably a very lubricious polymer. The outer tubing assembly allows the profile of the catheter to be minimized and yet provides significant kink-resistance to the inner tubing assembly. <IMAGE>
Patent DE-69733132-D1 (DE)
Inventor: SOKOL RONALD J
IPC: A61K33/04
Filed: 1997-01-15
Granted: 2005-06-02
Abstract: The present invention relates to formulations and methods for preventing and treating liver injury and fibrosis in cholestasis. This is accomplished by the administration of a composition which includes selected antioxidants.
Patent DE-69734605-D1 (DE)
Inventor: DARJI AYUB
IPC: A61P31/04
Filed: 1997-12-11
Granted: 2005-12-15
Abstract: The present invention is directed to an attenuated Salmonella comprising a eukaryotic expression vector for delivery of the eukaryotic expression vector to a eukaryotic cell. Delivery may be to eukaryotic cells cultured in vitro or to cells in vivo, such as by oral administration of the attenuated Salmonella comprising the eukaryotic expression vector.
Patent DE-69826828-D1 (DE)
Inventor: KADONO TOSHIKO
IPC: A23L1/30
Filed: 1998-10-14
Granted: 2004-11-11
Abstract: A reverse transcriptase containing flowery portion or its extract originated from elm in Ulmus hollandica is disclosed. The reverse transcriptase of this invention shows an activity remarkably higher than that of a known reverse transcriptase inhibitor derived from Ulmus davidiana var. japonica. Low toxicity of the reverse transcriptase inhibitor of this invention allows it being successfully applied to pharmaceuticals with a potent activity at a low dose, foods and beverages.
Patent DE-69901548-D1 (DE)
Inventor: ANDERSSON SVEN
IPC: F28D9/00
Filed: 1999-03-10
Granted: 2002-06-27
Abstract: In a three circuit plate heat exchanger stacked plates (31-36) forming channels for two flows (y, z) of fluid which should exchange heat with a third fluid (x) are each comprising two plate areas (20) surrounding two port forming holes and four plate areas (50) surrounding four port forming holes. The said two plate areas (20) surrounding two of the port holes are displaced through a vertical distance (H) away from the areas (50) surrounding four of the port forming holes. All channel forming plates are provided with a pressed pattern the maximum pressed depth of which is=h=about H/2.
Patent DE-69904931-D1 (DE)
Inventor: GILBERT J
IPC: H04M7/06
Filed: 1999-05-03
Granted: 2003-02-20
Abstract: A method and system for using TCAP signaling for improved call setup from a virtual switching point are disclosed. In accordance with the method, TCAP signaling is used to enhance call setup from virtual switching points which receive call request messages from calling parties using a facility on a data network such as the Internet. TCAP signaling is used when necessary to determine the availability of the called party telephone. The system includes a Virtual Switching Point (VSP) in a switched telephone network having a connection to a data network such as the Internet. Call requests are received by the VSP from the data network and processed by the VSP to establish a voice connection between the calling party which initiates the call request and a called party number indicated in the call request message. The use of TCAP signaling from the VSP to Switching Points (SPs) which serve the calling party and/or the called party improves efficiency and minimizes common channel signaling. The VSP enabled with TCAP signaling can also be used as an efficient out-dialer for a call center. The advantage is the ability to offer more calling options while improving network use efficiency.
Patent DE-69910060-D1 (DE)
Inventor: HSU S
IPC: H01M8/00
Filed: 1999-11-01
Granted: 2003-09-04
Abstract: A system and method for producing electricity with a fuel cell power system. The power system includes an assembly of fuel cell stacks that operate at different temperatures, which vary between two or more of the fuel cell stacks. The fuel cell stack can have multiple temperature regions formed axially along the stack, or a plurality of spatially separated fuel cell stacks can be employed to heat a reactant from an input temperature to a desired temperature. The fuel cell stacks have operating temperatures in the range between about 20 DEG  C. and about 2000 DEG  C.
Patent DE-69915351-D1 (DE)
Inventor: STOCKINGER FRIEDRICH
IPC: G02C7/04
Filed: 1999-11-18
Granted: 2004-04-08
Abstract: The invention relates to novel polyallyl amine polymers having a weight average molecular weight of at least 2000 that, based on the number of amino groups of the polyallyl amine, comprises from approximately 1 to 99 % of units of formula <CHEM> wherein R is as defined in the claims. The novel polyallyl amine polymers are useful, for example, for the surface-modification of different substrates or may be used for the manufacture of biomedical mouldings.
Patent DE-69923322-D1 (DE)
Inventor: CAVAZZA CLAUDIO
IPC: A61K33/243
Filed: 1999-07-27
Granted: 2005-02-24
Abstract: A method for preventing and/or treating peripheral neuropathies induced by the administration of an anticancer agent of the family of platin compounds, taxanes, epothilone class, vinca alkaloids, said method comprising the administration in a co-ordinated manner to a subject suffering from said peripheral neuropathies, or expected to suffer from said peripheral neuropathies, an effective amount of acetyl L-carnitine or of a pharmaceutically acceptable salt thereof. In case of prevention, acetyl L-carnitine is administered to a subject, in view of the need of a treatment with an anticancer agent, immediately before or immediately after surgical removal of the tumor, but in any case before the administration of the anticancer agent. Acetyl L-carnitine can enhance the supportive effect of physiological NGF during chemotherapy-induced neuropathy, thus avoiding the problem of the local and general side effects of the exogenous administration of NGF which are a major problem of this neuroprotective strategy.
Patent DE-69924148-D1 (DE)
Inventor: CORNEC RENE
IPC: F23N5/10
Filed: 1999-12-15
Granted: 2005-04-14
Abstract: The invention concerns a device for controlling a gas burner, comprising a detector (11) of the presence of a flame (12) at a point located at a specific distance from an orifice (3) of the burner flame, first means (7) controlling the gas flow rate feeding the burner, second processing means (10) receiving an information from the detector (11) and controlling the first means (7). The second processing means (10) increase the flow rate circulating in the first means (7) when they receive from the detector (11) an information representing the absence of flame (12) and the second processing means (10) reduce the flow rate circulating in the first means (7) when they receive from the detector (11) an information representing the presence of flame (12).
Patent DE-69925711-D1 (DE)
Inventor: DELLAVERSON LOU
IPC: H04W4/24
Filed: 1999-08-09
Granted: 2005-07-14
Abstract: A method of providing an information service in a communication system includes giving the user a plurality of options related to values of at least one communications parameter to be used during the provision of service, for selection therefrom by the user. Possible communications parameters are bandwidth, delay, error rate and communications route. The invention is particularly advantageous in network arrangements including cellular radio communication systems, such as UMTS.
Patent DE-69929535-D1 (DE)
Inventor: LONGONI FABIO
IPC: H04L9/00
Filed: 1999-11-05
Granted: 2006-04-06
Abstract: A mechanism for encrypting transmission of frames in a telecommunications network comprising a mobile station (MS), a radio network controller (SRNC) and at least one base station (BS1, BS2). The mobile station (MS) and each base station (BS1,BS2) have a corresponding timing reference (MSFN,BS1FN,BS2FN). The mechanism comprises the step of establishing a connection-specific timing reference which is common to all nodes (MS,BS1,BS2,RNC) involved in the connection and which comprises a common frame numbering scheme agreed between the mobile station (MS) and the radio network controller (SRNC) while establishing the connection, wherein said reference comprises a connection-specific frame number (CFN) and a frame number extension (HFN); the mobile station (MS) and the radio network controller (SRNC) use the CFN and the HFN for ciphering and deciphering the frames.
Patent DE-69929993-D1 (DE)
Inventor: BEHAN P
IPC: C12N15/16
Filed: 1999-10-12
Granted: 2006-04-27
Abstract: Disclosed herein are constitutively activated, non-endogenous versions of endogenous human G protein-coupled receptors comprising (a) the following amino acid sequence region (C-terminus to N-terminus orientation) and/or (b) the following nucleic acid sequence region (3' to 5' orientation) transversing the transmembrane-6 (TM6) and intracellular loop-3 (IC3) regions of the GPCR: (a) P<SUP>1 </SUP>AA<SUB>15</SUB>X and/or (b) p<SUP>codon </SUP>(AA-codon)<SUB>15 </SUB>X<SUB>codon</SUB>, respectively. In a most preferred embodiment, P<SUP>1 </SUP>and P<SUP>codon </SUP>are endogenous proline and an endogenous nucleic acid encoding region encoding proline, respectively, located within TM6 of the non-endogenous GPCR; AA<SUB>15 </SUB>and (AA-codon)<SUB>15 </SUB>are 15 endogenous amino acid residues and 15 codons encoding endogenous amino acid residues, respectively; and X and X<SUB>codon </SUB>are non-endogenous lysine and a non-endogenous nucleic acid encoding region encoding lysine, respectively, located within IC3 of the non-endogenous GPCR. Because it is most preferred that the non-endogenous human GPCRs which incorporate these mutations are incorporated into mammalian cells and utilized for the screening of candidate compounds, the non-endogenous human GPCR incorporating the mutation need not be purified and isolated per se (i.e., these are incorporated within the cellular membrane of a mammalian cell), although such purified and isolated non-endogenous human GPCRs are well within the purview of this disclosure.
Patent DE-69930053-D1 (DE)
Inventor: SUN SHIJUN
IPC: G06K9/64
Filed: 1999-09-27
Granted: 2006-04-27
Abstract: A template 38 is analyzed to determine step sizes for searching within a search area 40. The template is analyzed by first padding the template with data points to increase its size. Cross-correlation between the padded template 52 and the original template 38 leads to identification of an effective step size along multiple axes. Step sizes for each of a horizontal, vertical and, optionally, a third axis are derived. Third axis step sizes may correspond to rotation, scaling factor, subsampling factor, linear distance, time or frequency. Windows 42 of the search area 40, selected based on the step sizes, then are tested in a fast search by correlating the template to selected windows to derive correlation coefficients. Any tested window which has a correlation coefficient exceeding a given value is a potential match for the template and is subject to a refined stage of comparison. <IMAGE>
Patent DE-69939143-D1 (DE)
Inventor: SHIMADA KAZUMICHI
IPC: B41J2/175
Filed: 1999-08-27
Granted: 2008-09-04
Abstract: The technique of the present invention utilizes two different inks that are mixed with each other to express an achromatic color, in order to reduce the degree of granularity while decreasing the total quantity of inks. The black ink used in the present invention to create dots of black color is mixing black ink (Bk) that contains magenta and yellow dyes as well as a black dye, such as Food black, and thereby has a less quantity of the black dye. In order to express black color, dots of the mixing black ink (Bk) are mixed with dots of cyan ink (C), which compensates for a certain hue that is insufficient in a black color expressed by the mixing black ink (Bk). The mixing black ink (Bk) has higher lightness than a conventional real black ink and thereby reduces the degree of granularity in a resulting printed image. This arrangement of the invention enables creation of dots with the mixing black ink (Bk) to start from a lower density area, thereby reducing a total quantity of the respective color inks used for printing, which has a sufficient margin to a predetermined ink duty of paper. <IMAGE>